FibroBiologics (Equity)

Funding Details
Awarder
StartEngine
Date Award
February 01, 2023
Vertical
Cell Therapy Biotech and Pharmaceutical
Funding URL
View Funding Page
Premoney Valuation
$1,000,000
Valuation
$252,570,000

Company Info
Founding Year
2021
Traction
The company has raised over $4.999 million and has set records for the highest amount raised per biotech investor in StartEngine history. FibroBiologics has shown significant progress in its chronic wound program and has surpassed $3 million in just 9 days of fundraising.
Organizations Involved
None
Founders
Peter O'Heeron, Mark Andersen, Hamid Khoja
Company Description
FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.
Market
Healthcare
Location
Houston, TX, US
Coinvestors
None

Links
Back to Home Back to Cell Therapy Biotech and Pharmaceutical Deals View Funding Announcement